Osilodrostat (LCI699)
CAS: 928134-65-0
Ref. 3D-DMB13465
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
Osilodrostat (LCI699)
Controlled Product
Synonyms:
- Benzonitrile, 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluoro-
- 4-[(5R)-6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile
- Osilodrostat
- LCI 699
- 4-(R)-(6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluorobenzonitrile
Description:
Osilodrostat is a drug that inhibits the activity of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). It inhibits the conversion of cortisol to cortisone, which leads to an increase in cortisol levels. This drug has been shown to be effective in treating adrenocortical carcinoma by inhibiting the production of cortisol. Osilodrostat has a long half-life and may have therapeutic benefits in patients with congestive heart failure or renal disease. The drug also has anti-inflammatory properties, which can reduce the production of proinflammatory cytokines such as epidermal growth factor and aldosterone.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
227.24 g/mol
Formula:
C13H10FN3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
